A Phase 1, Single-Dose, Open-Label, 5-Treatment, Crossover, Pharmacokinetic Study of Comparative Bioavailability of Epinephrine Nasal Spray and EpiPen® in Healthy Adults With Seasonal Allergies

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.437
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search